AC Immune SA
NASDAQ:ACIU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
Informa PLC
LSE:INF
|
UK |
|
Lam Research Corp
NASDAQ:LRCX
|
US |
|
Barnes Group Inc
NYSE:B
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
CETC Acoustic-Optic-Electronic Technology Inc
SSE:600877
|
CN |
|
De' Longhi SpA
MIL:DLG
|
IT |
|
Weatherford International PLC
NASDAQ:WFRD
|
US |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
|
S
|
SBFC Finance Ltd
NSE:SBFC
|
IN |
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
US |
|
Coty Inc
PAR:COTY
|
US |
|
Fresnillo PLC
LSE:FRES
|
MX |
|
Babcock & Wilcox Enterprises Inc
NYSE:BW
|
US |
|
NAPCO Security Technologies Inc
NASDAQ:NSSC
|
US |
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
NL |
|
Triputra Agro Persada Tbk PT
IDX:TAPG
|
ID |
|
Wesco International Inc
NYSE:WCC
|
US |
|
KLX Energy Services Holdings Inc
NASDAQ:KLXE
|
US |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
George Weston Ltd
TSX:WN
|
CA |
|
Ares Commercial Real Estate Corp
NYSE:ACRE
|
US |
|
Xperi Holding Corp
LSE:0M2A
|
US |
|
Ryder System Inc
NYSE:R
|
US |
Bankruptcy Probability
AC Immune SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AC Immune SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
AC Immune SA
NASDAQ:ACIU
|
288m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AC Immune SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AC Immune SA has total debt of 3.5m CHF. This includes both short-term (0 CHF) and long-term (3.5m CHF) debt.
You can find a full breakdown on its Balance Sheet.
